Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort

Outcomes of the two generations of bioresorbable scaffolds (Magmaris vs. Absorb) in acute coronary syndrome in routine clinical practice

(2022) Piotr Rola et al.   Cardiology Journal

Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment

(2022) Aishah A Ekhzaimy et al.   Diabetes & Vascular Disease Research

Efficacy and Safety of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Peripheral Artery Disease: A Single-Arm Meta-Analysis

(2022) Weijian Fan et al.   JOURNAL OF ENDOVASCULAR THERAPY

Very long-term follow-up of patients with coronary bifurcation lesions treated with bioresorbable scaffolds

(2022) Sylwia Iwańczyk et al.   Kardiologia Polska

A First-in-Human Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Two-Year Clinical and Imaging Outcomes

(2022) Md. Misbahul Ferdous et al.   ADVANCES IN THERAPY

Coronary In-Stent Restenosis

(2022) Gennaro Giustino et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Approaches to Peripheral Artery Disease in Diabetes: Are There Any Differences?

(2022) Alexandru Achim et al.   International Journal of Environmental Research and Public Health

Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population

(2022) Arif Al Nooryani et al.   Journal of Clinical Medicine

The bioresorbable magnesium scaffold (Magmaris)—State of the art: From basic concept to clinical application

(2022) Piotr Rola et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options

(2022) Teresa Salvatore et al.   Biomedicines

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review

(2022) Attilio Leone et al.   Journal of Personalized Medicine

Magnesium Bioresorbable Scaffold (BRS) Magmaris vs Biodegradable Polymer DES Ultimaster in NSTE-ACS Population—12-Month Clinical Outcome

(2022) Piotr Rola et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy

(2021) Francesco Nappi et al.   Polymers

Long-term clinical follow-up of the resorbable magnesium scaffolds in acute coronary syndrome patients

(2021) Adrian Włodarczak et al.   Kardiologia Polska

Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds

(2021) Adrian Włodarczak et al.   Journal of Clinical Medicine

The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome

(2021) Adrian Włodarczak et al.   Journal of Clinical Medicine

Sustained safety and performance of a second-generation sirolimus-eluting absorbable metal scaffold: Long-term data of the BIOSOLVE-II first-in-man trial at 5 years

(2021) Michael Haude et al.   Cardiovascular Revascularization Medicine

Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents

(2021) Piotr Rola et al.   Journal of Diabetes Research

Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)

(2020) Mario Iannaccone et al.   BMC Cardiovascular Disorders

Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association

(2020) Suzanne V. Arnold et al.   CIRCULATION

Bioresorbable Polymeric Scaffold in Cardiovascular Applications

(2020) Daniel Wee Yee Toong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry

(2020) Cheol Hyun Lee et al.   PLoS One

Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent

(2020) Laura S.M. Kerkmeijer et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the “PSP” Technique

(2019) Zisis Dimitriadis et al.   Journal of Clinical Medicine

In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention

(2019) Xiaojun Zhuo et al.   MEDICINE

Safety and efficacy of the novel sirolimus‐eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One‐year results from a prospective patient‐level pooled analysis of NeoVas trials

(2019) Kai Xu et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

2-Year Clinical Outcomes of an Abluminal Groove–Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent

(2019) Bo Xu et al.   JACC-Cardiovascular Interventions

Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold

(2019) Bernard Chevalier et al.   Circulation-Cardiovascular Interventions

Long-term clinical results of biodegradable vascular scaffold ABSORB BVS™ using the PSP-technique in patients with acute coronary syndrome

(2019) Jarosław Hiczkiewicz et al.   Cardiology Journal

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds

(2018) Remzi Anadol et al.   BMC Cardiovascular Disorders

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

(2018) Hector M. Garcia-Garcia et al.   CIRCULATION

Coronary Stents: History, Design, and Construction

(2018) Torrey Schmidt et al.   Journal of Clinical Medicine

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies

(2018) Raminderjit Kaur et al.   Cardiovascular Diabetology

Fourth Universal Definition of Myocardial Infarction (2018)

(2018) Kristian Thygesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Role of Endothelium in Physiological and Pathological States: New Data

(2018) Agata Stanek et al.   Biomed Research International

Coronary Artery Disease and Type 2 Diabetes Mellitus

(2017) Ryo Naito et al.   International Heart Journal

Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus

(2017) Dean J. Kereiakes et al.   JACC-Cardiovascular Interventions

Macro- and microvascular endothelial dysfunction in diabetes

(2017) Yi Shi et al.   Journal of Diabetes

Stent Polymers

(2016) Konstantinos D. Rizas et al.   Circulation-Cardiovascular Interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

(2016) Michael Haude et al.   LANCET

Gender differences and bleeding complications after PCI on first and second generation DES

(2016) Wojciech Wanha et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds

(2014) Takashi Muramatsu et al.   JACC-Cardiovascular Interventions

Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

(2013) Fumiyuki Otsuka et al.   CIRCULATION

Impact of metabolic syndrome on re-stenosis development: Role of drug-eluting stents

(2012) SN Goyal et al.   Diabetes & Vascular Disease Research

Vascular Inflammation and Repair

(2011) Teruo Inoue et al.   JACC-Cardiovascular Interventions

Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents

(2010) Dean J. Kereiakes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY